Clinical Trial: To Explore the Safety and Efficacy of Hypervision Proton Surgery (HyPROS) for Early-stage Non-small Cell Lung Cancer

U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07195084) titled 'To Explore the Safety and Efficacy of Hypervision Proton Surgery (HyPROS) for Early-stage Non-small Cell Lung Cancer' on Sept. 18.

Brief Summary: This study was a single-center, single-arm clinical study to evaluate the safety and efficacy of hypervision proton surgery with single large fractionated doses (34GyE and 39GyE) in the treatment of early peripheral NSCLC.

Study Start Date: Sept. 20

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer

Intervention: RADIATION: Hypervision proton surgery

Proton radiaotherapy (34GyE or 39GyE)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Anhui Provincial Cancer Hospita...